Antonio Cigliola

Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Giorgio Brembilla, Giuseppe Basile, Michele Cosenza et al. · Radiology · 2024 · 25 citations · Full text

Medicine, Oncology, Urology +17

Use of 18F‐fluoro‐2‐deoxy‐ <scp>d</scp> ‐glucose <scp>(18F‐FDG) PET</scp> / <scp>CT</scp> for lymph node assessment before radical cystectomy in bladder cancer patients

Mattia Longoni, Pietro Scilipoti, Chiara Re et al. · British Journal of Urology · 2024 · 24 citations · Full text

Medicine, Oncology, Surgery +17

Association of Concomitant Bone Resorption Inhibitors With Overall Survival Among Patients With Metastatic Castration-Resistant Prostate Cancer and Bone Metastases Receiving Abiraterone Acetate With Prednisone as First-Line Therapy

Edoardo Francini, Francesca Montagnani, Pier Vitale Nuzzo et al. · JAMA Network Open · 2021 · 21 citations · Full text

Medicine, Oncology, Pharmacology +17

Vesical Imaging‐Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle‐invasive bladder cancer

Andrea Necchi, Giuseppe Basile, Ewan A. Gibb et al. · British Journal of Urology · 2023 · 21 citations · Full text

Medicine, Oncology, Urology +17

Comparative Effectiveness of Neoadjuvant Pembrolizumab Versus Cisplatin-based Chemotherapy or Upfront Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Cancer

Roger Li, Luigi Nocera, Kyle Rose et al. · European Urology Oncology · 2024 · 19 citations

Medicine, Oncology, Surgery +16